Structured Hybrid Mechanistic Models for Robust Estimation of Time-Dependent Intervention Outcomes

📅 2026-02-11
📈 Citations: 0
Influential: 0
📄 PDF

career value

206K/year
🤖 AI Summary
Accurately estimating the time-varying effects of interventions—such as drug administration—in dynamic systems is critical for mitigating dosing risks in out-of-distribution scenarios. This work proposes a structured hybrid modeling approach that decouples system dynamics into mechanistic (intervention-agnostic) and data-driven (intervention-dependent) components, thereby integrating prior mechanistic knowledge with nonparametric learning. The method innovatively employs a two-stage training strategy: when mechanistic parameters are unknown, an encoder is first pretrained on simulated data and subsequently fine-tuned on real-world data to correct residual discrepancies. Evaluated on both a pendulum system and a propofol bolus administration experiment, the proposed approach consistently outperforms purely mechanistic or purely data-driven models in both in-distribution and out-of-distribution settings, significantly enhancing the robustness and generalizability of intervention effect estimation.

Technology Category

Application Category

📝 Abstract
Estimating intervention effects in dynamical systems is crucial for outcome optimization. In medicine, such interventions arise in physiological regulation (e.g., cardiovascular system under fluid administration) and pharmacokinetics, among others. Propofol administration is an anesthetic intervention, where the challenge is to estimate the optimal dose required to achieve a target brain concentration for anesthesia, given patient characteristics, while avoiding under- or over-dosing. The pharmacokinetic state is characterized by drug concentrations across tissues, and its dynamics are governed by prior states, patient covariates, drug clearance, and drug administration. While data-driven models can capture complex dynamics, they often fail in out-of-distribution (OOD) regimes. Mechanistic models on the other hand are typically robust, but might be oversimplified. We propose a hybrid mechanistic-data-driven approach to estimate time-dependent intervention outcomes. Our approach decomposes the dynamical system's transition operator into parametric and nonparametric components, further distinguishing between intervention-related and unrelated dynamics. This structure leverages mechanistic anchors while learning residual patterns from data. For scenarios where mechanistic parameters are unknown, we introduce a two-stage procedure: first, pre-training an encoder on simulated data, and subsequently learning corrections from observed data. Two regimes with incomplete mechanistic knowledge are considered: periodic pendulum and Propofol bolus injections. Results demonstrate that our hybrid approach outperforms purely data-driven and mechanistic approaches, particularly OOD. This work highlights the potential of hybrid mechanistic-data-driven models for robust intervention optimization in complex, real-world dynamical systems.
Problem

Research questions and friction points this paper is trying to address.

intervention effect estimation
time-dependent outcomes
out-of-distribution robustness
pharmacokinetics
dynamical systems
Innovation

Methods, ideas, or system contributions that make the work stand out.

hybrid mechanistic-data-driven models
time-dependent intervention outcomes
out-of-distribution robustness
structured transition decomposition
two-stage learning
💼 Related Jobs
Postdoctoral Fellow – AI/ML Enabled Bioprocess Modeling and Control
Pfizer
The annual base salary for this position ranges from $64,600.00 to $107,600.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 7.5% of the base salary. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility.
United States - Massachusetts - Andover